Dr Dean Moss: Ledger

Role	Organisation	Sources
CEO	UniQuest	Mirage News, Startup Daily (25 Aug 2025), Business News Australia, materresearch.org.au, @AuManufacturing (4 Mar 2025), Startup News (WA), Startup Daily (28 Sep 2022), SmartCompany, @AuManufacturing (27 Sep 2022), Startup Daily (5 Apr 2022)

Coverage

Stories naming Dr Dean Moss. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Accelerator $1.5m

Vaccine Platform Secures Funds Against Mosquito Threats

UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.

Mirage News 21 Sep 2026 Proboxis Biotechnology Biointelect Medical Research Future Fund QIMR Berghofer UniQuest University of Queensland Biointelect Venturer Associate Professor Daniel Rawle Associate Professor Jody Peters Professor David Owen Dr Dean Moss Dr Henry de Malmanche Leah Goodman

Seed $2m

Queensland biotech tops up $1 million Seed round with another $2m

Queensland drug developer Lucia Bio added $2 million to its seed round from UniQuest Extension Fund and Uniseed-managed funds, bringing its overall raise to $3 million ahead of a planned Series A.

Startup Daily 25 Aug 2025 Lucia Bio Molecule to Medicine (MTM)The University of Queensland UniQuest Extension Fund UniQuest Uniseed Dr Dean Moss Dr Tom McCarthy

Unnamed stage $1m

UQ biotech innovation partnership forges a second startup

UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.

@AuManufacturing 4 Mar 2025 Curlew Bio Lucia Bio Mater Research Institute-UQ Molecule to Medicine Novartis Queensland Emory Drug Discovery Initiative Spinifex Pharmaceuticals The University of Queensland Translational Research Institute UniQuest UniQuest Extension Fund Dr Dean Moss Professor Katharina Ronacher Kirsty McCarthy Dr Tom McCarthy

3 deals

Pharma giant Pfizer wins over telehealth startup ResApp Health with $179 million takeover

Pfizer has completed its takeover of ASX-listed telehealth diagnostics company ResApp Health for $179 million, with the article recalling the company's 2015 listing, earlier raises and a Gates Foundation grant.

Startup Daily 28 Sep 2022 ResApp ACCC Bill & Melinda Gates Foundation Pfizer UniQuest University of Queensland Dr Dean Moss Professor Deborah Terry Dr Udantha Abeyratne

Exit / M&A

Pfizer acquires UQ spinout for $179 million

Pfizer has completed its purchase of Brisbane digital health company ResApp Health for $179 million, doubling its per-share offer after an April bid for the ASX-listed cough-diagnosis startup.

@AuManufacturing 27 Sep 2022 Bill & Melinda Gates Foundation Pfizer ResApp UniQuest University of Queensland Dr Dean Moss Dr Udantha Abeyratne

Also SmartCompany·Startup Daily·Startup Daily·Techboard·Startup News (WA)·sharecafe.com.au